|
TXNDC12 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.10422782029218E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.80829836952057E-11 |
| Normal-vs-Stage2 |
6.025600E-04 |
| Normal-vs-Stage3 |
6.53210818768457E-12 |
| Normal-vs-Stage4 |
2.11279993500568E-10 |
| Stage1-vs-Stage2 |
4.952600E-01 |
| Stage1-vs-Stage3 |
5.491600E-02 |
| Stage1-vs-Stage4 |
4.657600E-02 |
| Stage2-vs-Stage3 |
8.100300E-02 |
| Stage2-vs-Stage4 |
5.446400E-02 |
| Stage3-vs-Stage4 |
6.693200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.72804001610893E-12 |
| Normal-vs-AfricanAmerican |
2.939800E-03 |
| Normal-vs-Asian |
5.77009551250285E-11 |
| Caucasian-vs-AfricanAmerican |
4.889400E-01 |
| Caucasian-vs-Asian |
5.397000E-01 |
| AfricanAmerican-vs-Asian |
3.559600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.40309985852127E-10 |
| Normal-vs-Female |
3.86624066095465E-12 |
| Male-vs-Female |
9.355000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.57910018394603E-10 |
| Normal-vs-Age(41-60Yrs) |
8.19060375079061E-11 |
| Normal-vs-Age(61-80Yrs) |
1.08940000353996E-08 |
| Normal-vs-Age(81-100Yrs) |
1.635590E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.698000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.093800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.387600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.921800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.114400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.492400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.496100E-03 |
| Classical-VS-Follicular |
1.289350E-01 |
| Classical-VS-Other |
8.249400E-01 |
| Classical-VS-Normal |
8.52499959513864E-10 |
| Tall-VS-Follicular |
8.220200E-04 |
| Tall-VS-Other |
3.809000E-01 |
| Tall-VS-Normal |
6.40100195070659E-11 |
| Follicular-VS-Other |
8.451800E-01 |
| Follicular-VS-Normal |
6.558900E-04 |
| Other-VS-Normal |
2.471000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.47670036993497E-10 |
| Normal-vs-N1 |
1.65629732151729E-11 |
| N0-vs-N1 |
2.325900E-02 |
|
|
